Rss

Nexvet

Nexvet2018-07-31T16:12:16+00:00

Project Description

Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb) therapies for companion animals in pain and other therapeutic areas. Nexvet was acquired by Zoetis (NYSE:ZTS) in July 2017.

Nexvet acquired by Zoetis press release>>

If you are interested in becoming an Investor or seeking investment, then please contact us.

Forgot Password
Please enter your email address or username below.
*
Username OR Email Address
Username can not be left blank.
Please enter valid data.
Submit
 
Please Login
*
Username
Username can not be left blank.
Please enter valid data.
*
Password
Password can not be left blank.
Please enter valid data.
Please enter at least 1 characters.
LOGIN